抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號(hào) | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
StemRegenin 1，99% | C24H23N5OS | |||
|
|
|||||
|
RESIQUIMOD，98% | C17H22N4O2 | |||
|
|
|||||
|
Methoxy-PMS，97% | C15H16N2O5S | |||
|
|
|||||
|
MI 2 (MALT1 inhibitor)，99% | C19H17Cl3N4O3 | |||
|
|
|||||
|
YYA-021，98% | C18H27N3O2 | |||
|
|
|||||
|
MCC950 (sodium)，98% | C20H23N2NaO5S | |||
|
|
|||||
|
BMS-378806，98% | C22H22N4O4 | |||
|
|
|||||
|
Maraviroc，99% | C29H41F2N5O | |||
|
|
|||||
|
INF39，99% | C12H13ClO2 | |||
|
|
|||||
|
ESONARIMOD，98% | C14H16O4S | |||
|
|
|||||
|
HPGDS inhibitor 1，99% | C19H19F4N3O | |||
|
|
|||||
|
IRAK inhibitor 1，≥98% | C17H19N5 | |||
|
|
|||||
|
IRAK inhibitor 6，98% | C20H20N4O3S | |||
|
|
|||||
|
FK 3311，98% | C15H13F2NO4S | |||
|
|
|||||
|
TYRPHOSTIN AG 126，98% | C10H5N3O3 | |||
|
|
|||||
|
NOD-IN-1，98% | C18H17NO4S | |||
|
|
|||||
